- Home
- CMRX vs GBAB Comparison
CMRX vs GBAB Comparison
Compare CMRX & GBAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- GBAB
- Stock Information
- Founded
- CMRX 2000
- GBAB 2010
- Country
- CMRX United States
- GBAB United States
- Employees
- CMRX N/A
- GBAB N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- GBAB Investment Managers
- Sector
- CMRX Health Care
- GBAB Finance
- Exchange
- CMRX Nasdaq
- GBAB Nasdaq
- Market Cap
- CMRX 394.1M
- GBAB 387.9M
- IPO Year
- CMRX 2013
- GBAB N/A
- Fundamental
- Price
- CMRX $5.15
- GBAB $15.59
- Analyst Decision
- CMRX Strong Buy
- GBAB
- Analyst Count
- CMRX 2
- GBAB 0
- Target Price
- CMRX $8.50
- GBAB N/A
- AVG Volume (30 Days)
- CMRX 1.7M
- GBAB 69.4K
- Earning Date
- CMRX 03-07-2025
- GBAB 01-01-0001
- Dividend Yield
- CMRX N/A
- GBAB 9.18%
- EPS Growth
- CMRX N/A
- GBAB N/A
- EPS
- CMRX N/A
- GBAB N/A
- Revenue
- CMRX $159,000.00
- GBAB N/A
- Revenue This Year
- CMRX N/A
- GBAB N/A
- Revenue Next Year
- CMRX $1,690.28
- GBAB N/A
- P/E Ratio
- CMRX N/A
- GBAB N/A
- Revenue Growth
- CMRX N/A
- GBAB N/A
- 52 Week Low
- CMRX $0.75
- GBAB $14.22
- 52 Week High
- CMRX $5.53
- GBAB $17.44
- Technical
- Relative Strength Index (RSI)
- CMRX 76.25
- GBAB 50.42
- Support Level
- CMRX $3.94
- GBAB $15.36
- Resistance Level
- CMRX $5.53
- GBAB $15.63
- Average True Range (ATR)
- CMRX 0.30
- GBAB 0.18
- MACD
- CMRX 0.07
- GBAB -0.02
- Stochastic Oscillator
- CMRX 78.29
- GBAB 41.27
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest
Guggenheim Taxable Municipal Managed Duration Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.